475 related articles for article (PubMed ID: 27338066)
1. Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.
Wang YQ; Qu DH; Wang K
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2389-403. PubMed ID: 27338066
[TBL] [Abstract][Full Text] [Related]
2. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
3. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.
Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT
Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
5. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
6. Activation of α-secretase cleavage.
Postina R
J Neurochem; 2012 Jan; 120 Suppl 1():46-54. PubMed ID: 21883223
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
8. The non-amyloidogenic pathway: structure and function of alpha-secretases.
Kojro E; Fahrenholz F
Subcell Biochem; 2005; 38():105-27. PubMed ID: 15709475
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
10. Substrate-Specific Activation of α-Secretase by 7-Deoxy-Trans-Dihydronarciclasine Increases Non-Amyloidogenic Processing of β-Amyloid Protein Precursor.
Chun YS; Cho YY; Kwon OH; Zhao D; Yang HO; Chung S
Molecules; 2020 Feb; 25(3):. PubMed ID: 32028607
[TBL] [Abstract][Full Text] [Related]
11. Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model.
Guo C; Yang ZH; Zhang S; Chai R; Xue H; Zhang YH; Li JY; Wang ZY
Neuropsychopharmacology; 2017 Dec; 42(13):2504-2515. PubMed ID: 28079060
[TBL] [Abstract][Full Text] [Related]
12. The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein.
Delarasse C; Auger R; Gonnord P; Fontaine B; Kanellopoulos JM
J Biol Chem; 2011 Jan; 286(4):2596-606. PubMed ID: 21081501
[TBL] [Abstract][Full Text] [Related]
13. The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer s disease.
Hooper NM; Turner AJ
Curr Med Chem; 2002 Jun; 9(11):1107-19. PubMed ID: 12052175
[TBL] [Abstract][Full Text] [Related]
14. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
[TBL] [Abstract][Full Text] [Related]
15. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
16. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling.
Rossner S; Ueberham U; Schliebs R; Perez-Polo JR; Bigl V
Prog Neurobiol; 1998 Dec; 56(5):541-69. PubMed ID: 9775403
[TBL] [Abstract][Full Text] [Related]
17. Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
Li B; Yu D; Xu Z
Brain Res; 2014 Jan; 1545():35-44. PubMed ID: 24333930
[TBL] [Abstract][Full Text] [Related]
18. A closer look at alpha-secretase.
Postina R
Curr Alzheimer Res; 2008 Apr; 5(2):179-86. PubMed ID: 18393803
[TBL] [Abstract][Full Text] [Related]
19. Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study.
Welt T; Kulic L; Hoey SE; McAfoose J; Späni C; Chadha AS; Fisher A; Nitsch RM
J Alzheimers Dis; 2015; 46(4):971-82. PubMed ID: 25881909
[TBL] [Abstract][Full Text] [Related]
20. Double-Edged Roles of Nitric Oxide Signaling on APP Processing and Amyloid-β Production In Vitro: Preliminary Evidence from Sodium Nitroprusside.
Cai ZX; Guo HS; Wang C; Wei M; Cheng C; Yang ZF; Chen YW; Le WD; Li S
Neurotox Res; 2016 Jan; 29(1):21-34. PubMed ID: 26429731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
